Connect with us

Featured

Martha & Canopy CBD products to hit the market mid-2020

Published

on

Martha & Canopy

Also,2020 will be an important milestone when it comes to the progression of the Cannabis industry. Martha Steward’s CBD product line developed in collaboration with Canopy Growth- Canada based Marijuana company, will be ready to hit the shelves in the mid of the coming year.

This partnership was announced back in March, where Martha decided to contribute her efforts in the ever-growing cannabis industry. She took up an advisory role in the launch of these CBD products. She was to assist in the company in the development and positioning of broad range CBD products. Her experience and help played an important role in exploring the effectiveness of these products.

The big news about the date of the launch of Martha & Canopy CBD products was big news during Toronto’s Elevate Tech Fest’19. Stewart also discussed that she is working on several relevant projects with the company. She stated that they are working on many home products, foods and much more. Apart from this skincare products are also her primary interest. Also, they are considering pets products as well. Contrary to her previous engagements, these products are CBD based, which is a non-psychoactive ingredient of the cannabis plant.

Martha Stewart is a well-known name when it comes to recipes, DIYs and home décor ideas. In short, she is a lifestyle guru and diva that every cannabis lover should follow. Putting Martha’s face to this collaboration will surely steer her huge fan base and followers towards the acceptance of cannabis products and to view them open-mindedly. The hesitant consumers might also come forward. This will sever the purpose of creating social acceptance of CBD products. This Canadian-American cross over suggests that conditions are becoming more receptive to cannabis. Diva also hopes that cannabis will be legal in the U.S. in the coming days.

Many other celebrities are also into the cannabis business industry. Several also have products launched under their brand names. Snoop dog and Willie Nelson are among the list. Willie’s Remedies serves the medicinal purpose. One of their specialized products is coffee beans infusion with high-quality CBD oil. Snoop’s line under the brand name ‘Leaf by Snoops’ is more on the recreational side. Three varieties of cannabis were launched under this name.

Also read- Which Kardashian Has Joined the Cannabis Business?

Canopy Growth, formerly known as Tweed Marijuana Inc. is a leading cannabis company based in Smith Falls, Ontario. The company’s stocks are already in the New York stock exchange. Illegal trade on the enterprise is not allowed. The company doesn’t sell any products in the U.S. This collaboration is one of its kinds that will allow the Canadian company to introduce its products in the American world.

While many are still hesitant towards the utilization of cannabis products, ventures similar to these are opening gateways for the expansion of the industry. If the launch goes successful, new room of consumers would be generated.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

CBD and Sleep – What Researchers Have To Say

Published

on

Humans are unable to function at peak emotional, physical, and mental levels with a lack of a good night’s sleep. Insomnia, sleep apnea, narcolepsy, and other ailments, can cause the person to seek over the counter prescription pharmaceuticals for relief. Consequently, options like cannabis are being explored for natural sleep aid.

A sizable uptick was prompted by the insurgence of CBD, in the number of preclinical and clinical studies that were focusing on CBD’s value in the treatment of a whole host of disorders. However, studies focusing on CBD and sleep specifically are limited.

Although THC has shown to have a sedative effect and reduces the time needed to fall asleep, the harmonized interaction between cannabis compounds might carry over to sleep.

While THC is a sedative, it has other useful sleep properties as well such as causing catalepsy. According to Dr. Dustin Sulak, the proven effectiveness of CBD might be the sole reduction of anxiety which allows relaxation and the continuation of the person’s natural sleep mechanism.

Dosage-

CBD has reported giving either a stimulating or calming effect, depending on the consumer, which raises ambiguity. Although little, but research indicates that higher doses of CBD cause a calming effect, while lower doses cause a stimulating effect. CBD had reported giving hypnotic-like effects in a 1977 animal study. However, the little research that has been performed, proves that the effectiveness of CBD is dependant on the person’s presence or absence of a normal sleep rhythm or sleep disorder.

CBD and REM sleep

Certain sleep anomalies that occur during REM sleep, have been found to be helped by CBD. Non-rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep are the two types of sleep. NREM sleep is progressed through a 90-minute cycle, which eventually leads up to a REM sleep, where dreaming occurs along with an increase in brain wave activity. Furthermore, memory is solidified in REM sleep.

Limb muscles temporarily paralyze during normal REM sleep, so that a person is unable to act out his dreams. People are able to flail and act out vivid and violent dreams, in Parkinson’s disease and REM behavior disorder. Doses of CBD ranging from 75 to 300 mg were shown to help such patients, according to a preliminary study. Sleep cycles are not altered and people seem to keep awake by low-dose CBD formulations. However, the benefits for circadian rhythm disorders and narcolepsy could be proven in the near future as it may help people stay awake during daylight hours.

Should CBD be used for sleep?

The effect of CBD is highly individualized due to the uniqueness of every individual’s body. Sulak explained how a person’s negative response to THC, would cause him to be reluctant in using CBD on the same person. Some patients have shown high sensitivity to THC, along with impairment in the morning. Sulak recommends CBD strains that contain high levels of myrcene.

According to Sulak, although CBD may prove beneficial for people with sleep disturbances, pragmatically designed clinical trials are still important, with a recommended algorithm type approach.

Sulak ensures the safety of CBD, hence claiming higher doses of 100 to 200 mg of CBD to be safe as well if lower doses of 10 to 50 mg prove ineffective.

A 2018 study, that wasn’t initially aimed at CBD’s effects on sleep, still demonstrated the safety of CBD at higher doses of 1500mg to 6000mg. Furthermore, the National Academies of Sciences, Engineering, and Medicine had concluded in a 2017 report that despite the lack of specific CBD sleep studies, moderate evidence exists for the support of CBD to be proven effective to improve short-term sleep conditions.

Continue Reading

Cannabis

Cannabis Report 2019-2023 – Complete Guide for Investors

mm

Published

on

cannabis report

The cannabis market has a recent report of its progress in the US and there is a forecast released for the years 2019 to 2023 that will help newcomers in the market. The cannabis report provides extensive detail regarding the cannabis market in the United States of America that includes an intricate description of the market growth rate and size.

This report will be giving an analysis of the market in the United States of America regarding cannabis by depicting its values and segmentation. Moreover, the report has an in-depth analysis of all cannabis-derived products in the cannabis market through the product and the channel for product distribution.

Cannabidiol is the non-psychoactive component of cannabis that is available in both marijuana and hemp. These two are the types of the original plant.

The extraction of cannabidiol compounds is possible through giving heat or decarboxylating the CBD acid. The resultant product CBD does not induce and intoxication in the user and the user does not feel any high.

This compound found in the medical strains has many therapeutic benefits that help relieve chronic pain and is useful for a number of physical as well as psychological diseases.

Moreover, some studies suggest it to be helpful even for pets regarding anxiety and pain. That is the reason why many Americans are now bringing cannabis products home and making it a part of their daily routine.

In addition to these factors, the fact that cannabinoid also helps in the endocannabinoid system, it is rendered good for the immune system in humans.

It slows down the whole disease progressing state according to some studies. The strain is available in many different forms with varying THC and CBD content and their ratios if both are meant to be present in the same product.

The cannabidiol market has high hopes of becoming one of the most flourishing industries in the US market during these years.

Various growth-enhancing factors like aging population growth and cannabis culture getting promoted and advocated among millennials, increasing chronic pain diseases like arthritis and other diseases are some causes why cannabis is flourishing in the domestic as well as the international market.

Moreover, the removal of the hemp substance from the list of Controlled Substances Act has given it a legal edge due to which people are not avoiding the product from the fear of showing positive test results.

On the other side, the market is not yet marked safe from risks and challenges of any kind that hinder the progress of the crop. These issues include a vague legal framework and policy regarding cannabis cultivation and use and products that are not regulated.

The report regarding cannabis will be assessing the opportunities in the industry and outline the factors that would drive the growth of the industry. The growing cannabis market in the US in cultivating terms has also been forecasted in this report.

 

 

 

Continue Reading

Cannabis

Leading Brand to Participate in 2nd Annual Cannabis Conference

Published

on

cannabis conference

Khiron is a vertically integrated leading name in cannabis industry having its basic operations in South America. The company has just announced that it will be taking part in the Cowen 2nd Annual Boston Cannabis Conference. The conference will take place on November 12, Tuesday, 2019 to November 13, 2019 in Boston, Massachusetts.

The Intercontinental Hotel will be hosting the whole event where there will be fresh updates about all institutional investors in the market. These institutional investors will bring information regarding already existing as well as upcoming products in the market.

This will be a quite informative event targeted at bringing out all new investors at one platform and paving a way for future investments. That initiative will help the market to grow and become better in all cases.

There will be 15 high-interest panel discussions that will cover all topics that include cannabinoids in different aspects. Payments, retail, sustainability, legislation and regulation will be the highlights of the entire conference.

Furthermore, all American cannabis brands as well as international markets will be discussed by high think tanks and the senior management belonging to the cannabis market.

At the conference, Khiron Chief Executive Officer Alvaro Torres will also be present at the conference. They will be available for individualized and pre-booked meetings after the conference. In addition to that, Mr. Torres will be joining the panel discussion of the conference that will be covering the international cannabis markets.

Khiron Life Sciences Corporation is placed at the leading position in the cannabis retail market in the region of South America. Khiron has its operations in the region and is a fully licensed and registered name in Colombia for cultivating purposes. The company produces, locally distributes, and even exports medical cannabis.

THC – tetrahydrocannabinol, and CBD – cannabidiol, both components are available in the strains of medical cannabis they produce and sell in the market.

The organization has a best in class compliance for regulation for cannabis, and has the first approved cannabinoid domestic products for cosmetic purposes in the area of Colombia. Moreover, it is helping the facility testing for getting registered through an official license for its cannabis derived products for commercial usage.

The company has a regional strategy and moves with a patient oriented aim. It combines the global scientific expertise, innovation in agriculture, product name in brand and entrance idea in the market.

Brand loyalty and an educational experience also comes under the name of the targets this company wants to achieve. Moreover, alleviation of problems like chronic pain, anxiety, and other mental health problems in the region are also among the goals of this company.

Alvaro Torres has an experienced executive team under his company who is responsible for carrying out all major and minor technicalities and address tot the issues related to the company.

Continue Reading

Trending